SecSonar.com

Tempus AI, Inc. (TEM)

Tempus AI, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Tempus AI, Inc. (TEM) is a Medical - Healthcare Information Services company based in US with a market capitalization of $8.7B. Revenue grew 83.4% year-over-year and free cash flow was negative at -$239.1M. This page tracks TEM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2.4K employees · IPO Jun 14, 2024

Valuation

Valuation & price

$43.93 · as of May 17, 2026 · -57.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

17.76

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$103$72.94$42.62Jul 25Dec 25Jul 26Jul 7, 25$58.01Jul 9, 25$58.41Jul 11, 25$56.88Jul 15, 25$55.89Jul 17, 25$60.65Jul 21, 25$58.01Jul 23, 25$64.86Jul 25, 25$64.49Jul 29, 25$58.29Jul 31, 25$56.59Aug 4, 25$57.52Aug 6, 25$55.53Aug 11, 25$60.82Aug 13, 25$69.63Aug 15, 25$73.78Aug 19, 25$73.08Aug 21, 25$76.71Aug 25, 25$75.90Aug 27, 25$73.23Aug 29, 25$75.86Sep 3, 25$76.29Sep 5, 25$79.62Sep 9, 25$81.01Sep 11, 25$88.78Sep 16, 25$87.04Sep 18, 25$87.07Sep 22, 25$85.87Sep 24, 25$79.23Sep 26, 25$78.48Sep 30, 25$80.71Oct 2, 25$89.30Oct 6, 25$93.08Oct 8, 25$103.25Oct 10, 25$96.39Oct 14, 25$89.87Oct 16, 25$91.02Oct 21, 25$89.10Oct 23, 25$87.04Oct 27, 25$91.58Oct 29, 25$88.84Oct 31, 25$89.85Nov 4, 25$84.49Nov 6, 25$72.09Nov 10, 25$71.78Nov 12, 25$71.10Nov 14, 25$68.48Nov 18, 25$66.77Nov 20, 25$65.69Nov 25, 25$76.84Nov 28, 25$77.93Dec 2, 25$73.97Dec 4, 25$76.33Dec 8, 25$77.04Dec 10, 25$75.07Dec 12, 25$70.61Dec 16, 25$68.11Dec 18, 25$62.21Dec 22, 25$65.92Dec 24, 25$64.26Dec 29, 25$61.47Jan 2, 26$62.36Jan 6, 26$69.54Jan 8, 26$68.36Jan 12, 26$69.26Jan 14, 26$69.28Jan 16, 26$70.33Jan 21, 26$65.32Jan 23, 26$65.32Jan 27, 26$66.81Jan 29, 26$63.51Feb 2, 26$58.55Feb 4, 26$53.55Feb 9, 26$57.12Feb 11, 26$53.61Feb 13, 26$51.95Feb 18, 26$56.16Feb 20, 26$58.37Feb 24, 26$57.95Feb 26, 26$55.41Mar 2, 26$53.31Mar 4, 26$51.29Mar 6, 26$52.26Mar 10, 26$50.90Mar 12, 26$49.53Mar 17, 26$50.84Mar 19, 26$48.74Mar 23, 26$49.14Mar 25, 26$46.76Mar 27, 26$42.62Mar 31, 26$45.22Apr 2, 26$47.39Apr 7, 26$46.82Apr 9, 26$44.16Apr 13, 26$45.98Apr 15, 26$56.41Apr 17, 26$55.87Apr 22, 26$55.51Apr 24, 26$52.12Apr 28, 26$51.10Apr 30, 26$55.48May 4, 26$55.81May 6, 26$53.50May 8, 26$49.86May 12, 26$46.95May 14, 26$45.48May 18, 26$43.62May 20, 26$45.88May 22, 26$46.18May 28, 26$51.29Jun 1, 26$52.80Jun 3, 26$47.51Jun 5, 26$46.43Jun 9, 26$48.82Jun 11, 26$49.59Jun 15, 26$52.32Jun 17, 26$48.79Jun 22, 26$47.85Jun 24, 26$51.94Jun 26, 26$56.14Jul 2, 26$60.26
$42.3752-week range$103.25
Loading valuation history…

Fundamentals

Key fundamentals

$8.7B

Market cap

83.4%

Revenue growth (YoY)

69.6%

Gross margin

-$239.1M

Free cash flow (USD)

$60.7M

Net debt

7.5%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$62.1MFY 2020$188.0MFY 2021$257.9MFY 2022$320.7MFY 2023$531.8MFY 2024$693.4MFY 2025$1.3B
$62.1M$1.3B

Free cash flow by year

2019 → 2025

FY 2019$-134.1MFY 2020$-220.0MFY 2021$-223.8MFY 2022$-186.6MFY 2023$-248.9MFY 2024$-211.2MFY 2025$-239.1M
-$134.1M-$239.1M

Gross margin by year

2021 → 2025

FY 202132.4%FY 202240.6%FY 202353.8%FY 202455.0%FY 202569.6%
32.4%69.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

12

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $9.6M · 10b5-1 PlanLEFKOFSKY ERIC P · Director, CEO and Chairman, 10% Owner · $9.6MJul 1, 2026Filing
  • Insider sellInsider Sell $634K · 10b5-1 PlanRogers James William · Chief Financial Officer · $634.1KJun 29, 2026Filing
  • Insider sellInsider Sell $147K · 10b5-1 PlanDoudna Jennifer A · Director · $147KJun 29, 2026Filing
  • Insider sellInsider Sell $12K · 10b5-1 PlanEpstein David R · Director · $12.4KJun 3, 2026Filing
  • Insider sellInsider Sell $7.8M · 10b5-1 PlanLEFKOFSKY ERIC P · Director, CEO and Chairman, 10% Owner · $7.8MMay 29, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 22, 2026Filing
  • Insider sellInsider Sell $181KBartolucci Ryan M · Chief Accounting Officer · $181.4KMay 21, 2026Filing
  • Insider sellInsider Sell $597KFukushima Ryan · CEO, Data · $597.1KMay 21, 2026Filing
  • Insider sellInsider Sell $984KLEFKOFSKY ERIC P · Director, CEO and Chairman, 10% Owner · $984.3KMay 21, 2026Filing
  • Insider sellInsider Sell $384KPolovin Andrew · EVP, Chief Legal Officer · $383.5KMay 21, 2026Filing

Questions

Frequently asked questions

What is Tempus AI, Inc.'s market cap?

Tempus AI, Inc. (TEM) has a market capitalization of $8.7B.

What is TEM's P/E ratio?

A meaningful P/E ratio is not available for TEM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is TEM's price-to-book (P/B) ratio?

TEM trades at 17.76 times book value per share.

Are insiders buying TEM stock?

SEC Form 4 filings show no open-market insider buys at Tempus AI, Inc. in the last 90 days (12 sells).

Same arena

Related companies in Medical - Healthcare Information Services

HQY

HealthEquity, Inc.

$7.4B

BTSG

BrightSpring Health Services, Inc. Common Stock

$11.9B

HNGE

Hinge Health, Inc.

$4.4B

DOCS

Doximity, Inc.

$4B

TXG

10x Genomics, Inc.

$3.6B

HTFL

Heartflow, Inc. Common Stock

$2.7B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.